Logo - springer
Slogan - springer

Business & Management - Finance & Banking | Valuation in Life Sciences - A Practical Guide

Valuation in Life Sciences

A Practical Guide

Bogdan, Boris, Villiger, Ralph

3rd ed. 2010, XIV, 370 p.

Available Formats:
eBook
Information

Springer eBooks may be purchased by end-customers only and are sold without copy protection (DRM free). Instead, all eBooks include personalized watermarks. This means you can read the Springer eBooks across numerous devices such as Laptops, eReaders, and tablets.

You can pay for Springer eBooks with Visa, Mastercard, American Express or Paypal.

After the purchase you can directly download the eBook file or read it online in our Springer eBook Reader. Furthermore your eBook will be stored in your MySpringer account. So you can always re-download your eBooks.

 
$69.99

(net) price for USA

ISBN 978-3-642-10820-4

digitally watermarked, no DRM

Included Format: PDF

download immediately after purchase


learn more about Springer eBooks

add to marked items

Hardcover
Information

Hardcover version

You can pay for Springer Books with Visa, Mastercard, American Express or Paypal.

Standard shipping is free of charge for individual customers.

 
$89.95

(net) price for USA

ISBN 978-3-642-10819-8

free shipping for individuals worldwide

usually dispatched within 3 to 5 business days


add to marked items

Softcover
Information

Softcover (also known as softback) version.

You can pay for Springer Books with Visa, Mastercard, American Express or Paypal.

Standard shipping is free of charge for individual customers.

 
$89.95

(net) price for USA

ISBN 978-3-642-42584-4

free shipping for individuals worldwide

usually dispatched within 3 to 5 business days


add to marked items

  • First complete guide to valuation in life sciences (pharma, biotech, medtech)
  • Step-by-step explanation of how to practice valuation of projects and contracts
  • With relevant data and many real-life examples and exercises

This book is the first complete guide to valuation in life sciences for industry professionals, investors, and academics. Boris Bogdan and Ralph Villiger introduce the characteristics of drug and medical device development, explain how to translate these into the valuation, and provide valuable industry data. After guiding the reader through the theory of valuation, including DCF, decision trees, and real options, the authors demonstrate how to value projects, patents, licences, firms, and stocks on real-life examples, even treating complex licence and company structures. Special emphasis is put on the practicability of the proposed methods by including many hands-on examples, without compromising on realistic results.

The 3rd edition of the successful work includes new studies about success rates and about drug development in the biotech industry and their influence on valuation. 

Content Level » Professional/practitioner

Keywords » Biotech - Computerassistierte Detektion - Medtech - Pharma - Radiologieinformationssystem - Real Options - Valuation - Venture Capital - biotechnology - business - development - strategy

Related subjects » Health Informatics

Table of contents / Preface / Sample pages 

Popular Content within this publication 

 

Articles

Read this Book on Springerlink

Services for this book

New Book Alert

Get alerted on new Springer publications in the subject area of Finance / Banking.